Cited by 1,002

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cancer survival in five continents: a worldwide population-based study (CONCORD)

Coleman, Michel P, Quaresma, Manuela, Berrino, Franco, Lutz, Jean-Michel, De Angelis, Roberta, Capocaccia, Riccardo, Baili, Paolo, Rachet, Bernard, Gatta, Gemma, Hakulinen, Timo, Micheli, Andrea, Sant, Milena, Weir, Hannah K, Elwood, J Mark, Tsukuma, Hideaki, Koifman, Sergio, e Silva, Gulnar Azevedo, Francisci, Silvia, Santaquilani, Mariano, Verdecchia, Arduino, Storm, Hans H, Young, John L·2008·The Lancet Oncology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(08)70179-7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Decrease in cancer mortality after 1990 resulted from both decrease in incidence and increase in survival.

    “Decrease in mortality after 1990 resulted from both decrease in incidence and increase in survival (Coleman et al., 2008).”

    From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Coleman et al., 2008

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 82

  1. Hakulinen, 1983, A comparison of nationwide cancer survival statistics in Finland and Norway, World Health Stat Q, 36, 35
  2. Engeland, 1998, Relative survival of cancer patients: a comparison between Denmark and other Nordic countries, Acta Oncol, 37, 49, 10.1080/028418698423177 · DOI
  3. Gorey, 1998, An international comparison of cancer survival: advantage of Toronto's poor over the near-poor of Detroit, Rev Canad Santé Publ, 89, 102
  4. Verdecchia, 2003, Comparison of stomach cancer incidence and survival in four continents, Eur J Cancer, 39, 1603, 10.1016/S0959-8049(03)00360-5 · DOI
  5. Gatta, 2000, Toward a comparison of survival in American and European cancer patients, Cancer, 89, 893, 10.1002/1097-0142(20000815)89:4<893::AID-CNCR24>3.0.CO;2-9 · DOI
  6. Sant, 2004, Breast carcinoma survival in Europe and the USA: a population-based study, Cancer, 100, 715, 10.1002/cncr.20038 · DOI
  7. Gatta, 2002, Childhood cancer survival in Europe and the United States, Cancer, 95, 1767, 10.1002/cncr.10833 · DOI
  8. Gatta, 2003, Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology, Eur J Cancer, 39, 2214, 10.1016/S0959-8049(03)00549-5 · DOI
  9. McDavid, 2004, Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study, Cancer Causes Control, 15, 1057
  10. Allemani, 2006, Hodgkin disease survival in Europe and the US: prognostic significance of morphologic groups, Cancer, 107, 352, 10.1002/cncr.21995 · DOI
  11. Capocaccia, 2007, Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th Century, Am J Gastroenterol, 102, 1661, 10.1111/j.1572-0241.2007.01337.x · DOI
  12. Sant, 2008, Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States, Eur J Cancer, 44, 579, 10.1016/j.ejca.2007.12.016 · DOI
  13. Berkson, 1950, Calculation of survival rates for cancer, Proc Staff Meet Mayo Clinic, 25, 270
  14. Ederer, 1961, The relative survival: a statistical methodology, Natl Cancer Inst Monogr, 6, 101
  15. Farrow, 1996, Regional variation in survival following the diagnosis of cancer, J Clin Epidemiol, 49, 843, 10.1016/0895-4356(96)00176-X · DOI
  16. Coleman, 2003, EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century, Ann Oncol, 14, 128, 10.1093/annonc/mdg756 · DOI
  17. Sant, 2003, EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary, Ann Oncol, 14, 61, 10.1093/annonc/mdg754 · DOI
  18. 2003, Ann Oncol, 14, 1
  19. Berrino, 2007, Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study, Lancet Oncol, 8, 773, 10.1016/S1470-2045(07)70245-0 · DOI
  20. Verdecchia, 2007, Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data, Lancet Oncol, 8, 784, 10.1016/S1470-2045(07)70246-2 · DOI
  21. Capocaccia, 2003, The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis, Ann Oncol, 14, 14, 10.1093/annonc/mdg751 · DOI
  22. Hakulinen, 1982, Cancer survival corrected for heterogeneity in patient withdrawal, Biometrics, 38, 933, 10.2307/2529873 · DOI
  23. Baili P, Micheli A, De Angelis R, et al. CONCORD Working Group, CONCORD study: comparable life tables for world-wide analysis of relative survival for cancer. Tumori (in press).
  24. Brawley, 1999, Race and outcomes: is this the end of the beginning for minority health research?, J Natl Cancer Inst, 91, 1908, 10.1093/jnci/91.22.1908 · DOI
  25. Richardson, 1992, Stage and delay in breast cancer diagnosis by race, socio-economic status, age and year, Br J Cancer, 65, 922, 10.1038/bjc.1992.193 · DOI
  26. Ansell, 1993, Race, income, and survival from breast cancer at two public hospitals, Cancer, 72, 2974, 10.1002/1097-0142(19931115)72:10<2974::AID-CNCR2820721019>3.0.CO;2-M · DOI
  27. Greenwald, 1996, Race, socioeconomic status and survival in three female cancers, Ethn Health, 1, 65, 10.1080/13557858.1996.9961771 · DOI
  28. Dignam, 2000, Differences in breast cancer prognosis among African-American and Caucasian women, CA Cancer J Clin, 50, 50
  29. Dignam, 1999, Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project, J Natl Cancer Inst, 91, 1933, 10.1093/jnci/91.22.1933 · DOI
  30. Bach, 2002, Survival of blacks and whites after a cancer diagnosis, J Amer Med Assoc, 287, 2106, 10.1001/jama.287.16.2106 · DOI
  31. Farooq, 2005, Breast cancer survival in South Asian women in England and Wales, J Epidemiol Community Health, 59, 402, 10.1136/jech.2004.030965 · DOI
  32. dos Santos Silva, 2003, Survival from breast cancer among South Asian and non-South Asian women resident in South East England, Br J Cancer, 89, 508, 10.1038/sj.bjc.6601097 · DOI
  33. Hakulinen, 1977, On long-term relative survival rates, J Chron Dis, 30, 431, 10.1016/0021-9681(77)90036-4 · DOI
  34. Estève, 1990, Relative survival and the estimation of net survival: elements for further discussion, Stat Med, 9, 529, 10.1002/sim.4780090506 · DOI
  35. Spiegelhalter, 2005, Funnel plots for comparing institutional performance, Stat Med, 24, 1185, 10.1002/sim.1970 · DOI · Paper page
  36. Pisani, 1999, Estimates of the worldwide mortality from 25 major cancers in 1990, Int J Cancer, 83, 18, 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M · DOI
  37. Bray, 2004, The changing global patterns of female breast cancer incidence and mortality, Breast Cancer Res, 6, 229, 10.1186/bcr932 · DOI
  38. Bailar, 1997, Cancer undefeated, N Engl J Med, 336, 1569, 10.1056/NEJM199705293362206 · DOI
  39. Bailar, 1986, Progress against cancer?, N Engl J Med, 314, 1226, 10.1056/NEJM198605083141905 · DOI
  40. Doll, 1990, Are we winning the fight against cancer?, Eur J Cancer, 26, 500, 10.1016/0277-5379(90)90025-O · DOI
  41. Doll, 1992, Are we winning the war against cancer? A review in memory of Keith Durrant, Clin Oncol, 4, 257, 10.1016/S0936-6555(05)81065-9 · DOI
  42. Doll, 1989, Progress against cancer: are we winning the war?, Acta Oncol, 28, 611, 10.3109/02841868909092281 · DOI
  43. Percy, 1978, Comparison of the coding of death certificates related to cancer in seven countries, Public Health Rep, 93, 335
  44. Percy, 1974, Apparent changes in cancer mortality, 1968: a study of the effects of the introduction of the eighth revision International Classification of Diseases, Public Health Rep, 89, 418
  45. 1990, Measurement of progress against cancer, J Natl Cancer Inst, 82, 825, 10.1093/jnci/82.10.825 · DOI
  46. Richards, 2007, EUROCARE-4 studies bring new data on cancer survival, Lancet Oncol, 8, 752, 10.1016/S1470-2045(07)70247-4 · DOI
  47. Coleman, 2000, Trends in breast cancer incidence, survival and mortality, Lancet, 356, 590, 10.1016/S0140-6736(00)02593-9 · DOI
  48. Tsukuma, 2006, Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan, Jpn J Clin Oncol, 36, 602, 10.1093/jjco/hyl068 · DOI
  49. Brenner, 1995, Limitations of the death certificate only index as a measure of incompleteness of cancer registration, Br J Cancer, 72, 506, 10.1038/bjc.1995.363 · DOI
  50. Robinson, 2007, Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates, Eur J Cancer, 43, 909, 10.1016/j.ejca.2007.01.007 · DOI
  51. Berrino, 2003, The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies, Ann Oncol, 14, 9, 10.1093/annonc/mdg750 · DOI
  52. Schlemper, 2000, Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma, Cancer, 82, 60, 10.1002/(SICI)1097-0142(19980101)82:1<60::AID-CNCR7>3.0.CO;2-O · DOI
  53. Cooper, 1998, Pathology of the malignant colorectal polyp, Hum Pathol, 29, 15, 10.1016/S0046-8177(98)90385-9 · DOI
  54. van der Esch, 1991, Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely, Int J Cancer, 47, 483, 10.1002/ijc.2910470402 · DOI
  55. Gondos, 2004, Cancer survival in a southern African urban population, Int J Cancer, 112, 860, 10.1002/ijc.20471 · DOI
  56. Boschmonar, 2000, Childhood cancer survival in Cuba, Eur J Epidemiol, 16, 763, 10.1023/A:1026793615987 · DOI
  57. Yu, 2004, Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites, Br J Cancer, 91, 1663, 10.1038/sj.bjc.6602154 · DOI
  58. Ciccolallo, 2005, Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery, Gut, 54, 268, 10.1136/gut.2004.044214 · DOI
  59. Young, 1984, Cancer patient survival among ethnic groups in the United States, J Natl Cancer Inst, 73, 341, 10.1093/jnci/73.2.341 · DOI
  60. Woods, 2005, Choice of geographic unit influences socioeconomic inequalities in breast cancer survival, Br J Cancer, 92, 1279, 10.1038/sj.bjc.6602506 · DOI
  61. McDavid, 2003, Cancer survival in Kentucky and health insurance coverage, Arch Intern Med, 163, 2135, 10.1001/archinte.163.18.2135 · DOI
  62. Sinha, 2007, Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients, Anticancer Res, 27, 3135
  63. Halpern, 2008, Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis, Lancet Oncol, 9, 222, 10.1016/S1470-2045(08)70032-9 · DOI
  64. Bradley, 2002, Race, socioeconomic status and breast cancer treatment and survival, J Natl Cancer Inst, 94, 490, 10.1093/jnci/94.7.490 · DOI
  65. VanEenwyk, 2002, Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum, Cancer, 95, 39, 10.1002/cncr.10645 · DOI
  66. Mayberry, 1995, Determinants of black/white differences in colon cancer survival, J Natl Cancer Inst, 87, 1686, 10.1093/jnci/87.22.1686 · DOI
  67. Shavers, 2002, Racial and ethnic disparities in the receipt of cancer treatment, J Natl Cancer Inst, 94, 334, 10.1093/jnci/94.5.334 · DOI
  68. Ward, 2004, Cancer disparities by race/ethnicity and socioeconomic status, CA Cancer J Clin, 54, 78
  69. Rabeneck, 2003, Survival of colorectal cancer patients hospitalized in the Veterans Affairs health care system, Amer J Gastroenterol, 98, 1186, 10.1111/j.1572-0241.2003.07448.x · DOI
  70. Brawley, 2002, Disaggregating the effects of race and poverty on breast cancer outcomes, J Natl Cancer Inst, 94, 471, 10.1093/jnci/94.7.471 · DOI
  71. Mariotto, 2002, Projecting SEER cancer survival rates to the US: an ecological regression approach, Cancer Causes Control, 13, 101
  72. Bossard, 2007, Survival of cancer patients in France: a population-based study from the Association of French Cancer Registries (FRANCIM), Eur J Cancer, 43, 149, 10.1016/j.ejca.2006.07.021 · DOI
  73. Brasso, 1998, Prostate cancer in Denmark: a 50-year population-based study, Urology, 51, 590, 10.1016/S0090-4295(97)00705-X · DOI
  74. Borre, 2007, Screening for prostatacancer—hvad siger evidensen?, Ugeskr Læger, 169, 1887
  75. 2006, Prostatacancer 2006—status og nye udfordringer, Ugeskr Læger, 168, 1243
  76. Parkin, 2006, The evolution of the population-based cancer registry, Nat Rev Cancer, 6, 603, 10.1038/nrc1948 · DOI
  77. Verdecchia, 2008, Patient survival for all cancers combined as indicator of cancer control in Europe, Eur J Public Health, 10.1093/eurpub/ckn022 · DOI
  78. Micheli, 2003, Cancer control in Europe: a proposed set of European Cancer Health Indicators, Eur J Public Health, 13, 1, 10.1093/eurpub/13.suppl_3.116 · DOI
  79. Gorey, 2000, An international comparison of cancer survival: relatively poor areas of Toronto, Ontario and three US metropolitan areas, J Public Health Med, 22, 343, 10.1093/pubmed/22.3.343 · DOI
  80. Sankaranarayanan, 1996, Global variations in cancer survival, Cancer, 78, 2461, 10.1002/(SICI)1097-0142(19961215)78:12<2461::AID-CNCR2>3.0.CO;2-N · DOI
  81. Woods, 2006, Origins of socio-economic inequalities in cancer survival: a review, Ann Oncol, 17, 5, 10.1093/annonc/mdj007 · DOI
  82. Kogevinas, 1997, Socioeconomic differences in cancer survival: a review of the evidence, 177

Cited by

Sorted by citations

Metadata

Authors
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., Micheli, A., Sant, M., Weir, H. K., Elwood, J. M., Tsukuma, H., Koifman, S., e Silva, G. A., Francisci, S., Santaquilani, M., Verdecchia, A., Storm, H. H., & Young, J. L.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2008-08
Volume
9
Issue
8
Pages
730-756
ISSN
1470-2045
Cited by
1,002
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review